Journal
INTENSIVE CARE MEDICINE
Volume 29, Issue 2, Pages 325-328Publisher
SPRINGER-VERLAG
DOI: 10.1007/s00134-002-1609-7
Keywords
heparin, therapeutic use; heparin, administration and dosage; partial thromboplastin time; monitoring; physiological, methods
Categories
Ask authors/readers for more resources
Objective: To determine the correlation between activated clotting time (ACT) and activated partial thromboplastin time (aPTT) in patients receiving intravenous unfractionated heparin therapy, and the accuracy of the ACT in predicting the level of anticoagulation. Design: Paired aPTT and ACT measurements were obtained from a convenience sample of critically ill patients requiring intravenous unfractionated heparin. The aPTT was determined in the hospital laboratory and ACT measurements were performed with a portable device. Setting: The intensive care unit of Ghent University Hospital, a tertiary care facility with 54 beds. Patients and participants: Twenty-eight patients were studied prospectively; a total of 105 paired samples were obtained. The indication for heparin therapy was cerebral ischemia in 8, various cardiac conditions in 10, pulmonary embolism in 3, continuous hemofiltration in 3, and peripheral arterial thrombosis in 4. Results: There was a significant correlation between aPTT and ACT. Analysis of variance showed a significant difference in ACT between different levels of anticoagulation, aPTT shorter than 60 s (group 1), aPTT 60-90 s (group 2), and aPTT longer than 90 s (group 3): 142 +/- 16.7 s in group I vs. 155 +/- 29.6 and 192 +/- 39.1 in groups 2 and 3. Conclusions: The correlation between the aPTT and the ACT in this ICU setting is poor; ACT cannot differentiate between low and therapeutic levels of anticoagulation. The use of the ACT for monitoring low to moderate doses of heparin in ICU patients cannot be recommended.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available